-
Advertorial
-
FOCUS
-
Guide
-
Lifestyle
-
Tech and Vogue
-
TechandScience
-
CHTF Special
-
Nanhan
-
Asian Games
-
Hit Bravo
-
Special Report
-
Junior Journalist Program
-
World Economy
-
Opinion
-
Diversions
-
Hotels
-
Movies
-
People
-
Person of the week
-
Weekend
-
Photo Highlights
-
Currency Focus
-
Kaleidoscope
-
Tech and Science
-
News Picks
-
Yes Teens
-
Fun
-
Budding Writers
-
Campus
-
Glamour
-
News
-
Digital Paper
-
Food drink
-
Majors_Forum
-
Speak Shenzhen
-
Business_Markets
-
Shopping
-
Travel
-
Restaurants
-
Hotels
-
Investment
-
Yearend Review
-
In depth
-
Leisure Highlights
-
Sports
-
World
-
QINGDAO TODAY
-
Entertainment
-
Business
-
Markets
-
Culture
-
China
-
Shenzhen
-
Important news
在线翻译:
szdaily -> Business
Chinese firm targets US GMO market
     2015-December-8  08:53    Shenzhen Daily

    A CHINESE biotech seed firm is aiming to launch the country’s first genetically modified corn products overseas on the home turf of the world’s top agricultural companies, as the Chinese Government’s reticence over GMO food keeps the domestic market off limits.

    The plan by Beijing-based Origin Agritech to test its technology in the United States, which has dominated the sector with GMO (genetically modified organism) giants such as Monsanto, is the latest effort by a Chinese firm to enter the global industry.

    Earlier this year, China National Chemical Corp. sought to skirt obstacles at home and acquire a tried-and-tested GMO pipeline by bidding for the world’s top agrichemicals firm Swiss-based Syngenta.

    The Chinese Government’s GMO policy has at times appeared inconsistent — billions of dollars have been spent on developing technology it hopes will ensure supplies for its 1.4 billion people while no major food crops have been approved for cultivation given deep-seated anti-GMO sentiment in the country. Bumper harvests in the past decade have also reduced the urgency for new technologies.

    “Consumer attitude is one thing, but the government attitude is even more important,” said Huang Dafang, professor at the Biotechnology Research Institute under the Chinese Academy of Agricultural Sciences. That leaves firms like Origin with few options to earn revenues from GMO products in China, he added.

    U.S.-listed Origin has invested 300 million yuan (US$46.90 million) in biotech since 2005 and, without an opportunity to market its product at home, it now plans to enter the United States in 2016.

    Entering the U.S. market could take several paths from licensing its technology to setting up a unit there, Origin’s chief financial officer, James Chen, told Reuters. But getting a foothold in such a highly competitive market will not be easy, experts warn.

    Origin’s most advanced product is a corn with two special characteristics, or “traits,” that resist pests while top seed firm Monsanto already markets a GMO corn that combines or “stacks” as many as eight traits to combat pests.(SD-Agencies)

深圳报业集团版权所有, 未经授权禁止复制; Copyright 2010, All Rights Reserved.
Shenzhen Daily E-mail:szdaily@szszd.com.cn